Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136


Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.

Kim JY, Kim OY, Paik JK, Lee SH, Lee JH.

J Clin Lipidol. 2013 Mar-Apr;7(2):94-101. doi: 10.1016/j.jacl.2012.06.002. Epub 2012 Jun 28.


APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.

Jang Y, Chae JS, Kim OY, Park HJ, Kim JY, Paik JK, Lee SH, Lee JH.

Atherosclerosis. 2010 Aug;211(2):512-9. doi: 10.1016/j.atherosclerosis.2010.03.014. Epub 2010 Mar 16.


The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.

Talmud PJ, Cooper JA, Hattori H, Miller IP, Miller GJ, Humphries SE.

Diabetologia. 2006 Oct;49(10):2337-40. Epub 2006 Aug 18.


Contribution of APOA5-1131C allele to the increased susceptibility of diabetes mellitus in association with higher triglyceride in Korean women.

Lee KH, Kim OY, Lim HH, Lee YJ, Jang Y, Lee JH.

Metabolism. 2010 Nov;59(11):1583-90. doi: 10.1016/j.metabol.2010.02.008. Epub 2010 Mar 29.


The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.

Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, Lee SH, Shin DJ, Ordovas JM, Lee JH.

Clin Chim Acta. 2009 Apr;402(1-2):83-7. doi: 10.1016/j.cca.2008.12.024. Epub 2008 Dec 31.


APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.

Zhang X, Qi Q, Bray GA, Hu FB, Sacks FM, Qi L.

Am J Clin Nutr. 2012 Oct;96(4):917-22. Epub 2012 Aug 22.


Influence of adiponectin gene polymorphisms on adiponectin level and insulin resistance index in response to dietary intervention in overweight-obese patients with impaired fasting glucose or newly diagnosed type 2 diabetes.

Chung HK, Chae JS, Hyun YJ, Paik JK, Kim JY, Jang Y, Kwon HM, Song YD, Lee HC, Lee JH.

Diabetes Care. 2009 Apr;32(4):552-8. doi: 10.2337/dc08-1605. Epub 2009 Jan 8.


Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.

Perez-Martinez P, Corella D, Shen J, Arnett DK, Yiannakouris N, Tai ES, Orho-Melander M, Tucker KL, Tsai M, Straka RJ, Province M, Kai CS, Perez-Jimenez F, Lai CQ, Lopez-Miranda J, Guillen M, Parnell LD, Borecki I, Kathiresan S, Ordovas JM.

Am J Clin Nutr. 2009 Jan;89(1):391-9. doi: 10.3945/ajcn.2008.26363. Epub 2008 Dec 3.


The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.

Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Guardiola M, Heras M, Masana L.

Nutr Metab Cardiovasc Dis. 2010 May;20(4):243-8. doi: 10.1016/j.numecd.2009.04.003. Epub 2009 Sep 17.


Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population.

Zhai G, Wen P, Guo L, Chen L.

Clin Chem Lab Med. 2006;44(11):1313-6.


Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.

Chandak GR, Ward KJ, Yajnik CS, Pandit AN, Bavdekar A, Joglekar CV, Fall CH, Mohankrishna P, Wilkin TJ, Metcalf BS, Weedon MN, Frayling TM, Hattersley AT.

BMC Med Genet. 2006 Oct 10;7:76.


Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.

Dallinga-Thie GM, van Tol A, Hattori H, van Vark-van der Zee LC, Jansen H, Sijbrands EJ; DALI study group..

Diabetologia. 2006 Jul;49(7):1505-11. Epub 2006 Apr 28.


Increased risk of obesity related to total energy intake with the APOA5-1131T > C polymorphism in Korean premenopausal women.

Lim HH, Choi M, Kim JY, Lee JH, Kim OY.

Nutr Res. 2014 Oct;34(10):827-36. doi: 10.1016/j.nutres.2014.08.018. Epub 2014 Sep 6.


Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.

Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, Parnell LD, Tucker KL, Ordovas JM.

Circulation. 2006 May 2;113(17):2062-70. Epub 2006 Apr 24.


Supplemental Content

Support Center